Royalty Pharma RPRX
NASDAQ RPRX
$63.86 +0.11 (+0.17%)
At close: Oct 23, 2026 · 4:00 PM EDT

Royalty Pharma (RPRX) Return on Sales [ROS] (2019 - 2026)

Updated

Royalty Pharma (RPRX) reported Return on Sales [ROS] of 19.75% for Q2 2026, down 16.51 percentage points from 36.26% a year earlier and down 69.54 percentage points from the prior quarter.

Analysis

Royalty Pharma (RPRX) Return on Sales [ROS] (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Royalty Pharma's Return on Sales [ROS] came in at 59.61%, down 20.23 percentage points year-over-year; for FY2025, it came in at 65.58%, up 8.48 percentage points from FY2024.

  • Return on Sales [ROS] has a five-year change of -9.60 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at 57.10% in FY2024 (-6.28 pp), 63.37% in FY2023 (+49.65 pp), 13.73% in FY2022 (-48.77 pp) and 62.49% in FY2021 (-12.68 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Sales [ROS] since Q1 2024.
  • Year over year, Return on Sales [ROS] gained in three of the last eight quarters, with an average year-over-year change of +9.17 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q4 2023 (a gain of 188.14 percentage points); the low point was Q4 2022 (a drop of 111.96 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 89.29% (Q1 2026), 62.44% (Q4 2025) and 70.11% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Rocket Companies 44.05 Bn 29.73 Bn - 23.53%
2 Orix 40.96 Bn 10.18 Bn 12.74 Bn 6.19%
3 Royalty Pharma 36.72 Bn 36.63 Bn - 19.75%
4 Affirm Holdings 23.63 Bn 17.32 Bn - 12.63%
5 Federal National Mortgage Association Fannie Mae 23.47 Bn 23.47 Bn - 507.88%
6 Synchrony Financial 22.90 Bn -44.72 Bn - 43.96%
7 Royal Gold 19.26 Bn 18.48 Bn 390.45 Mn 62.13%
8 Annaly Capital Management 13.77 Bn 4.86 Bn - 278.44%
9 Ares Capital 13.38 Bn 10.82 Bn - -
10 Federal Home Loan Mortgage 12.16 Bn -6.58 Bn - 551.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.75%
Mar 31, 2026 89.29%
Dec 31, 2025 62.44%
Sep 30, 2025 70.11%
Jun 30, 2025 36.26%
Mar 31, 2025 94.01%
Dec 31, 2024 60.90%
Sep 30, 2024 130.17%
Jun 30, 2024 50.19%
Mar 31, 2024 -12.99%
Dec 31, 2023 102.82%
Sep 30, 2023 28.24%
Jun 30, 2023 46.24%
Mar 31, 2023 70.03%
Dec 31, 2022 -85.31%
Sep 30, 2022 33.52%
Jun 30, 2022 70.49%
Mar 31, 2022 39.09%
Dec 31, 2021 26.65%
Sep 30, 2021 51.74%
API Access

Royalty Pharma Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RPRX&period=max&api_key=YOUR_API_KEY